Asthma Drug Cuts Seasonal Flares for Inner-City Kids – MedPage Today

Asthma Drug Cuts Seasonal Flares for Inner-City Kids
MedPage Today
Explain that a monoclonal antibody directed against IgE (omalizumab) improved asthma symptoms and reduced the need for other controller medications among inner-city children with persistent allergic asthma
Xolair Relieves Kids' Seasonal Asthma Attacks: StudyWebMD
Omalizumab Improves Asthma Control in Inner-City ChildrenMedscape
Xolair Reduces Seasonal Asthma Attacks for Inner City Kids: StudyU.S. News & World Report
Bloomberg –7Online.com –Internal Medicine News Digital Network
all 24 news articles »

View full post on asthma – Google News

Xolair Relieves Kids’ Seasonal Asthma Attacks: Study – WebMD

Xolair Relieves Kids' Seasonal Asthma Attacks: Study
WebMD
March 16, 2011 — The asthma drug Xolair (omalizumab) improves asthma control, nearly eliminates seasonal flare-ups, and allows reductions in the doses of other asthma control medications in children as young as 6, according to a new
Novartis, Roche's Xolair Helps Stop Asthma Attacks in ChildrenBloomberg

all 2 news articles »

View full post on asthma – Google News